Stephen J. Dipalma serves as Executive at INTERLEUKIN GENETICS INC, where they oversee executive responsibilities. Since joining the company, Stephen J. Dipalma has executed 2 insider transactions totaling $35.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 29, 2016 involved purchasing 100,603 shares valued at $10.1K.
Stephen J. Dipalma currently holds 349,855 shares of INTERLEUKIN GENETICS INC (ILIU), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stephen J. Dipalma has been a net buyer of ILIU stock. They have purchased $35.0K and sold $0 worth of shares.
Stephen J. Dipalma's most recent insider trade was on Jul 29, 2016, when they purchased 100,603 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $0.10 |
| Discretionary |